A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.
Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM.
Martin NE, et al. Among authors: delaney tf.
Clin Cancer Res. 2004 Aug 15;10(16):5447-54. doi: 10.1158/1078-0432.CCR-04-0248.
Clin Cancer Res. 2004.
PMID: 15328183
Clinical Trial.